A bumper crop of revisions, including a stronger drug benefit, means the Medicare plan you enrolled in for 2024 may not be ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

Mexico is facing a second Donald Trump presidency, and few countries can match its experience as a target of Trump’s rhetoric ...

Even though Biogen raised earnings guidance, the company still has “some potentially concerning signals” in its base business ...

Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...

Harriett said he is telling clients who want to buy a particular drug plan that doesn’t pay him commission that ... them CMS canceled their certification – they can’t write business, they can’t be ...

Results from OVATION 2 Study of IMNN-001 to be highlighted in late-breaking acceptanceCompany also announces FDA End-of-Phase 2 in-person meeting ...

Former Town Supervisor Mike Sweeton recalls the day in 2011 when he learned the state was closing Mid-Orange Correctional Facility. The call came from a prison staff member on a Friday afternoon ...

Humana's stock has fallen over 30% due to rising healthcare utilization and CMS pushing back on insurer profits, impacting MA ...

Cryptocurrency more than doubles since January on hopes of lighter regulation; latest share sale takes UK Treasury’s holding ...

Ocugen ( OCGN -6.48%) Q3 2024 Earnings Call Nov 08, 2024, 8:30 a.m. ET Good morning and welcome to Ocugen's third quarter 2024 financial results and business update. [Operator instructions] I will now ...

A bumper crop of revisions, including a stronger drug benefit, means the plan you enrolled in for 2024 ... However, plans are permitted to vie for your business by making more competitive offers ...